Also on Monday, drug developer Artiva Biotherapeutics Inc. unveiled a price range on an estimated $131 million IPO scheduled for this week. Artiva joins hospital operator Ardent Health and insurance distributor TWFG Inc., who are planning sizable IPOs this week.
Lineage also said its underwriters will have a 30-day option to buy an additional 7.05 million shares at the IPO prices, potentially boosting proceeds to more than $4 billion.
Legal Representation
Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, BofA Securities Inc., J.P. Morgan Securities LLC, and Wells Fargo Securities LLC are among the lead underwriters for Lineage.
A Latham team led by partners Julian T.H. Kleindorfer and Lewis Kneib is representing Lineage. A Goodwin team led by partners Scott Chase and David Roberts is representing the underwriters. Venable LLP is also representing Lineage on matters regarding Maryland law. Lineage plans to convert its operating partnership, called Lineage OP LLC, currently based in Delaware, to a Maryland limited partnership as part of the IPO.
